The New Yorker:

If you or someone you love has cancer, cardiovascular disease, dementia, Parkinson’s disease, or diabetes, you have likely benefitted from the university’s federally funded discoveries in care and treatment.

By Atul Gawande

It did not take long for Harvard’s leadership to realize that the university would have to stand up to the Trump Administration. On March 31st, the White House announced that the status of nine billion dollars in multiyear federal funding to the university and its affiliated hospitals was in question, pending review of alleged antisemitism on campus. A week and a half later, the Administration delivered an ultimatum that dispensed with that pretense: it issued no findings on the university’s antisemitism response but instead issued far more extensive demands.

In order to “maintain Harvard’s financial relationship with the federal government,” the letter stated, it must agree to, among other things: share with the government all hiring and admissions data through 2028, including on rejected student applicants; submit to the government an external audit of the views of all faculty, staff, and students, to show that every department and unit has established “viewpoint diversity”; reduce the power held by selected faculty members based on their “activism”; and audit numerous departments, including in the medical school, the school of public health, the divinity school, and the school of education, for alleged antisemitism.

Go to link